Clinical Trial Update: Ketoanalogue Supplementation for Muscle Protection in CKD 4 and 5 Patients With Moderately Low Protein Diet (KETO-PROT-ACTION) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating ketoanalogue supplementation to protect muscle in patients with advanced chronic kidney disease on a moderately low protein …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Ketoanalogue supplementation (ketoanalogue amino acid supplement)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Kidney Disease, Chronic | Phase 3 | Status: RECRUITING